[(1S,3R,6R,7S,8S,11S,12S,15R,16R)-7,12,16-trimethyl-15-[(2R)-6-methyl-5-oxoheptan-2-yl]-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] acetate

Details

Top
Internal ID 94f98b4b-b4df-4e68-9a7a-b0c8e7f1b3fc
Taxonomy Lipids and lipid-like molecules > Steroids and steroid derivatives > Cycloartanols and derivatives
IUPAC Name [(1S,3R,6R,7S,8S,11S,12S,15R,16R)-7,12,16-trimethyl-15-[(2R)-6-methyl-5-oxoheptan-2-yl]-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] acetate
SMILES (Canonical) CC1C2CCC3C4(CCC(C4(CCC35C2(C5)CCC1OC(=O)C)C)C(C)CCC(=O)C(C)C)C
SMILES (Isomeric) C[C@H]1[C@@H]2CC[C@H]3[C@@]4(CC[C@@H]([C@]4(CC[C@@]35[C@@]2(C5)CC[C@H]1OC(=O)C)C)[C@H](C)CCC(=O)C(C)C)C
InChI InChI=1S/C31H50O3/c1-19(2)25(33)10-8-20(3)23-12-14-29(7)27-11-9-24-21(4)26(34-22(5)32)13-15-30(24)18-31(27,30)17-16-28(23,29)6/h19-21,23-24,26-27H,8-18H2,1-7H3/t20-,21+,23-,24+,26-,27+,28-,29+,30-,31+/m1/s1
InChI Key MFJNHWBWIPQHAM-HYPAYZJTSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C31H50O3
Molecular Weight 470.70 g/mol
Exact Mass 470.37599545 g/mol
Topological Polar Surface Area (TPSA) 43.40 Ų
XlogP 8.50
Atomic LogP (AlogP) 7.61
H-Bond Acceptor 3
H-Bond Donor 0
Rotatable Bonds 6

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(1S,3R,6R,7S,8S,11S,12S,15R,16R)-7,12,16-trimethyl-15-[(2R)-6-methyl-5-oxoheptan-2-yl]-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl] acetate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9945 99.45%
Caco-2 - 0.6620 66.20%
Blood Brain Barrier + 0.6750 67.50%
Human oral bioavailability - 0.7286 72.86%
Subcellular localzation Mitochondria 0.7981 79.81%
OATP2B1 inhibitior - 0.7040 70.40%
OATP1B1 inhibitior + 0.8415 84.15%
OATP1B3 inhibitior + 0.9506 95.06%
MATE1 inhibitior - 0.8800 88.00%
OCT2 inhibitior - 0.6750 67.50%
BSEP inhibitior + 0.8639 86.39%
P-glycoprotein inhibitior + 0.6377 63.77%
P-glycoprotein substrate - 0.6091 60.91%
CYP3A4 substrate + 0.6917 69.17%
CYP2C9 substrate - 0.6048 60.48%
CYP2D6 substrate - 0.8427 84.27%
CYP3A4 inhibition - 0.8906 89.06%
CYP2C9 inhibition - 0.6752 67.52%
CYP2C19 inhibition - 0.7149 71.49%
CYP2D6 inhibition - 0.9625 96.25%
CYP1A2 inhibition - 0.9399 93.99%
CYP2C8 inhibition - 0.5818 58.18%
CYP inhibitory promiscuity - 0.8921 89.21%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.6442 64.42%
Eye corrosion - 0.9839 98.39%
Eye irritation - 0.8802 88.02%
Skin irritation - 0.6228 62.28%
Skin corrosion - 0.9437 94.37%
Ames mutagenesis - 0.7282 72.82%
Human Ether-a-go-go-Related Gene inhibition - 0.4450 44.50%
Micronuclear - 0.7500 75.00%
Hepatotoxicity - 0.6455 64.55%
skin sensitisation - 0.6564 65.64%
Respiratory toxicity + 0.5667 56.67%
Reproductive toxicity + 0.8667 86.67%
Mitochondrial toxicity + 0.6500 65.00%
Nephrotoxicity - 0.7289 72.89%
Acute Oral Toxicity (c) III 0.7362 73.62%
Estrogen receptor binding + 0.8006 80.06%
Androgen receptor binding + 0.7660 76.60%
Thyroid receptor binding + 0.5450 54.50%
Glucocorticoid receptor binding + 0.7429 74.29%
Aromatase binding + 0.6613 66.13%
PPAR gamma + 0.6572 65.72%
Honey bee toxicity - 0.6495 64.95%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity - 0.5755 57.55%
Fish aquatic toxicity + 0.9955 99.55%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 98.01% 97.25%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.18% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 96.57% 91.11%
CHEMBL2581 P07339 Cathepsin D 93.75% 98.95%
CHEMBL3837 P07711 Cathepsin L 93.43% 96.61%
CHEMBL1966 Q02127 Dihydroorotate dehydrogenase 90.19% 96.09%
CHEMBL340 P08684 Cytochrome P450 3A4 89.83% 91.19%
CHEMBL2996 Q05655 Protein kinase C delta 89.07% 97.79%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 88.88% 94.45%
CHEMBL6136 O60341 Lysine-specific histone demethylase 1 88.73% 95.58%
CHEMBL3137262 O60341 LSD1/CoREST complex 87.67% 97.09%
CHEMBL4681 P42330 Aldo-keto-reductase family 1 member C3 87.35% 89.05%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 86.12% 95.17%
CHEMBL218 P21554 Cannabinoid CB1 receptor 85.97% 96.61%
CHEMBL4793 Q86TI2 Dipeptidyl peptidase IX 85.30% 96.95%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 85.04% 92.62%
CHEMBL4227 P25090 Lipoxin A4 receptor 84.73% 100.00%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 83.80% 95.89%
CHEMBL3060 Q9Y345 Glycine transporter 2 83.58% 99.17%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 83.35% 93.00%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 83.27% 91.24%
CHEMBL221 P23219 Cyclooxygenase-1 83.06% 90.17%
CHEMBL3045 P05771 Protein kinase C beta 82.68% 97.63%
CHEMBL4026 P40763 Signal transducer and activator of transcription 3 82.53% 82.69%
CHEMBL233 P35372 Mu opioid receptor 82.51% 97.93%
CHEMBL3145 P42338 PI3-kinase p110-beta subunit 82.36% 98.75%
CHEMBL1994 P08235 Mineralocorticoid receptor 82.06% 100.00%
CHEMBL2413 P32246 C-C chemokine receptor type 1 81.90% 89.50%
CHEMBL1937 Q92769 Histone deacetylase 2 81.50% 94.75%
CHEMBL2007625 O75874 Isocitrate dehydrogenase [NADP] cytoplasmic 80.98% 99.00%
CHEMBL5203 P33316 dUTP pyrophosphatase 80.66% 99.18%
CHEMBL237 P41145 Kappa opioid receptor 80.35% 98.10%
CHEMBL3492 P49721 Proteasome Macropain subunit 80.14% 90.24%

Cross-Links

Top
PubChem 72708917
NPASS NPC270573